
    <!DOCTYPE html>
    <html>
    <head>
        <style>
            body { 
                font-family: 'Segoe UI', Roboto, -apple-system, sans-serif; 
                max-width: 1200px; 
                margin: 0 auto; 
                padding: 20px; 
                background-color: #f0f2f5;
                line-height: 1.6;
            }
            .container { 
                background-color: white; 
                padding: 40px; 
                border-radius: 16px; 
                box-shadow: 0 4px 12px rgba(0,0,0,0.1);
            }
            .agent-section { 
                margin-bottom: 35px; 
                padding: 25px; 
                border-radius: 12px; 
                transition: all 0.3s ease;
            }
            .agent-section:hover {
                transform: translateY(-2px);
                box-shadow: 0 4px 15px rgba(0,0,0,0.1);
            }
            .final-annotation { 
                background-color: #f0f7ff; 
                border-left: 5px solid #2196f3; 
            }
            .validator { 
                background-color: #f0fdf4; 
                border-left: 5px solid #22c55e; 
            }
            .formatting { 
                background: linear-gradient(145deg, #fff7ed, #ffe4c4);
                border-left: 5px solid #f97316; 
                box-shadow: 0 4px 15px rgba(249, 115, 22, 0.1);
            }
            h2 { 
                color: #1a2b3c; 
                margin-top: 0; 
                font-size: 1.5rem;
                font-weight: 600;
                display: flex;
                align-items: center;
                gap: 10px;
            }
            ul { 
                margin: 15px 0; 
                padding-left: 20px; 
            }
            pre { 
                background-color: #f8fafc; 
                padding: 20px; 
                border-radius: 8px; 
                overflow-x: auto;
                font-family: 'Consolas', 'Monaco', monospace;
                font-size: 0.9rem;
                line-height: 1.5;
            }
            .validation-result { 
                font-weight: 600; 
                color: #16a34a; 
                padding: 12px 20px;
                background-color: #dcfce7; 
                border-radius: 8px; 
                display: inline-block;
                margin: 10px 0;
            }
            br { 
                margin-bottom: 8px; 
            }
            p {
                margin: 12px 0;
                color: #374151;
            }
            .summary-content {
                display: flex;
                flex-direction: column;
                gap: 24px;
            }
            .summary-item {
                display: flex;
                flex-direction: column;
                gap: 8px;
                background: rgba(255, 255, 255, 0.7);
                padding: 16px;
                border-radius: 12px;
                backdrop-filter: blur(8px);
                box-shadow: 0 2px 8px rgba(0, 0, 0, 0.05);
            }
            .summary-label {
                font-weight: 600;
                color: #c2410c;
                font-size: 0.95rem;
                text-transform: uppercase;
                letter-spacing: 0.5px;
            }
            .summary-value {
                color: #1f2937;
                font-size: 1.1rem;
                padding: 8px 16px;
                background-color: rgba(255, 255, 255, 0.9);
                border-radius: 8px;
                display: inline-block;
                box-shadow: 0 1px 3px rgba(0, 0, 0, 0.1);
            }
            .summary-list {
                margin: 0;
                padding-left: 24px;
                list-style-type: none;
            }
            .summary-list li {
                color: #1f2937;
                padding: 8px 0;
                position: relative;
            }
            .summary-list li:before {
                content: "‚Ä¢";
                color: #f97316;
                font-weight: bold;
                position: absolute;
                left: -20px;
            }
            .report-header {
                text-align: center;
                margin-bottom: 40px;
                padding-bottom: 30px;
                border-bottom: 2px solid rgba(249, 115, 22, 0.2);
            }
            
            .report-title {
                font-size: 2.5rem;
                font-weight: 800;
                color: #1a2b3c;
                margin: 0;
                padding: 0;
                background: linear-gradient(135deg, #f97316, #c2410c);
                -webkit-background-clip: text;
                -webkit-text-fill-color: transparent;
                letter-spacing: -0.5px;
            }
            
            .report-subtitle {
                font-size: 1.1rem;
                color: #64748b;
                margin-top: 8px;
                font-weight: 500;
            }
            .scoring { 
                background: linear-gradient(145deg, #f0fdf4, #dcfce7);
                border-left: 5px solid #22c55e;
                box-shadow: 0 4px 15px rgba(34, 197, 94, 0.1);
            }
            .scoring-content {
                display: flex;
                flex-direction: column;
                gap: 16px;
                color: #1f2937;
                line-height: 1.8;
            }
            .scoring-content br + br {
                content: "";
                display: block;
                margin: 12px 0;
            }
            .empty-list {
                color: #6b7280;
                font-style: italic;
            }
            .error-message {
                color: #dc2626;
                padding: 12px;
                background-color: #fef2f2;
                border-radius: 6px;
                border-left: 4px solid #dc2626;
            }
            .score-badge {
                background: linear-gradient(135deg, #22c55e, #16a34a);
                color: white;
                padding: 8px 16px;
                border-radius: 12px;
                font-size: 1.5rem;
                font-weight: 700;
                display: inline-block;
                margin: 12px 0;
                box-shadow: 0 4px 12px rgba(34, 197, 94, 0.2);
                position: relative;
                top: -10px;
            }
            .score-badge::before {
                content: "Score:";
                font-size: 0.9rem;
                font-weight: 500;
                margin-right: 8px;
                opacity: 0.9;
            }
        </style>
    </head>
    <body>
        <div class="container">
            <div class="report-header">
                <h1 class="report-title">CASSIA Analysis Report</h1>
                <p class="report-subtitle">Comprehensive Cell Type Analysis and Annotation</p>
            </div>
            
                <div class="agent-section final-annotation">
                    <h2>üîç Final Annotation Analysis</h2>
                    To annotate the cell type from the provided ranked marker list, we will follow the outlined steps:<br><br>### Step 1: List the Key Functional Markers<br>- **ACTA2 (Alpha-Smooth Muscle Actin)**: Typically associated with smooth muscle cells and myofibroblasts, indicating contractile function.<br>- **MYH11 (Myosin Heavy Chain 11)**: A marker for smooth muscle cells, involved in muscle contraction.<br>- **MYLK (Myosin Light Chain Kinase)**: Plays a role in muscle contraction, particularly in smooth muscle cells.<br>- **CALD1 (Caldesmon 1)**: Involved in smooth muscle contraction.<br>- **TPM2 (Tropomyosin 2)**: Associated with actin filaments in muscle cells, indicating contractile properties.<br>- **ACTG2 (Actin Gamma 2)**: Another actin isoform found in smooth muscle cells.<br>- **TAGLN (Transgelin)**: A marker for smooth muscle cells, involved in actin binding and stabilization.<br>- **CALML3 (Calmodulin-like 3)**: Involved in calcium signaling, which is crucial for muscle contraction.<br>- **CRYAB (Alpha B-Crystallin)**: A small heat shock protein, often upregulated in response to stress, including in muscle cells.<br><br>### Step 2: List the Key Cell Type Markers<br>- **KRT5 (Keratin 5) and KRT14 (Keratin 14)**: Markers for basal epithelial cells, often found in the basal layer of the epidermis and in some epithelial cancers.<br>- **KRT17 (Keratin 17)**: Associated with basal/myoepithelial cells in the breast and other epithelial tissues.<br>- **COL17A1 (Collagen Type XVII Alpha 1 Chain)**: Found in epithelial cells, particularly in the basement membrane zone.<br>- **S100A2**: A marker for epithelial cells, often associated with basal-like breast cancer.<br>- **DST (Dystonin)**: Associated with epithelial cells, particularly in maintaining cell structure.<br>- **LAMB3 (Laminin Subunit Beta 3)**: Part of the basement membrane, associated with epithelial cells.<br>- **TNC (Tenascin C)**: An extracellular matrix protein, often upregulated in cancer and associated with epithelial-mesenchymal transition (EMT).<br><br>### Step 3: Cross-reference Known Databases<br>Using databases such as the Human Protein Atlas, CellMarker, and literature on breast cancer, we can cross-reference these markers:<br>- The presence of **ACTA2, MYH11, MYLK, CALD1, TPM2, ACTG2, TAGLN** suggests a smooth muscle or myoepithelial origin.<br>- **KRT5, KRT14, KRT17, COL17A1, S100A2** are indicative of basal/myoepithelial cells in the breast.<br><br>### Step 4: Determine the Most Probable General Cell Type<br>Based on the expression of these markers, the most likely general cell type is **myoepithelial cells**. These cells are known for their contractile properties and are found in the breast tissue, particularly in the basal layer.<br><br>### Step 5: Identify the Top 3 Most Probable Sub Cell Types<br>1. **Myoepithelial Cells**: Given the strong expression of smooth muscle and basal epithelial markers.<br>2. **Basal Epithelial Cells**: Due to the presence of keratins and other basal markers.<br>3. **Smooth Muscle Cells**: Although less likely in breast tissue, the contractile markers suggest this as a possibility.<br><br>The most likely subtype, based on the markers, is **myoepithelial cells**.<br><br>### Step 6: Provide a Concise Summary of Your Analysis<br>The ranked marker list from the breast cancer tissue dataset suggests that the cell cluster is most likely composed of myoepithelial cells. This conclusion is supported by the presence of both smooth muscle and basal epithelial markers, which are characteristic of myoepithelial cells in the breast. These cells play a crucial role in the structural integrity and function of the mammary gland, particularly in the context of breast cancer.<br><br>FINAL ANNOTATION COMPLETED
                </div>
            
                <div class="agent-section validator">
                    <h2>‚úì Validation Check</h2>
                    <div class="validation-result">‚úÖ VALIDATION PASSED</div>
                    Validation result: VALIDATION PASSED<br><br>The proposed annotation result is consistent with the provided marker list and the identified cell type. Here's the breakdown:<br><br>1. **Marker Consistency**: <br>   - The markers used in the annotation (e.g., ACTA2, MYH11, MYLK, CALD1, TPM2, ACTG2, TAGLN, KRT5, KRT14, KRT17, COL17A1, S100A2, DST, LAMB3, TNC) are all present in the provided marker list.<br>   - The markers are consistent with the identified cell type, myoepithelial cells, which are known to express both smooth muscle and basal epithelial markers.<br><br>2. **Mixed Cell Type Consideration**:<br>   - The annotation acknowledges the presence of both smooth muscle and basal epithelial markers, which is characteristic of myoepithelial cells. <br>   - The analysis considers the possibility of basal epithelial and smooth muscle cells but concludes that myoepithelial cells are the most likely subtype, which is reasonable given the context of breast tissue.<br><br>The annotation process has been thorough, considering both the functional and cell type-specific markers, and the conclusion aligns well with the known biology of myoepithelial cells in breast tissue.
                </div>
            
                        <div class="agent-section formatting">
                            <h2>üìã Summary</h2>
                            
                        <div class="summary-content">
                            <div class="summary-item">
                                <span class="summary-label">Main Cell Type:</span>
                                <span class="summary-value">myoepithelial cells</span>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Sub Cell Types:</span>
                                <ul class="summary-list">
                                    <li>basal epithelial cells</li><li>smooth muscle cells</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Possible Mixed Cell Types:</span>
                                <ul class="summary-list">
                                    <li class="empty-list">No mixed cell types identified</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Number of Markers:</span>
                                <span class="summary-value">50</span>
                            </div>
                        </div>
                    
                        </div>
                    
                    <div class="agent-section scoring">
                        <h2>üéØ Quality Assessment</h2>
                        <div class="score-badge">90</div>
                        <div class="scoring-content">
                            The annotation results provided demonstrate a well-structured approach to identifying the cell type from the given marker list. The analysis correctly identifies myoepithelial cells as the main cell type, which is consistent with the presence of both smooth muscle and basal epithelial markers. This is a scientifically accurate conclusion given the context of human breast cancer tissue, where myoepithelial cells are known to play a significant role.<br><br>Strengths of the annotation include:<br>1. **Comprehensive Marker Analysis**: The annotation process effectively considers a wide range of markers, including ACTA2, MYH11, MYLK, CALD1, TPM2, ACTG2, TAGLN, KRT5, KRT14, KRT17, COL17A1, and S100A2. These markers are relevant to both smooth muscle and basal epithelial cells, supporting the identification of myoepithelial cells.<br>2. **Balanced Consideration**: The analysis does not overly focus on a single marker but instead integrates multiple markers to form a cohesive understanding of the cell type. This balanced approach is crucial for accurate annotation.<br>3. **Cross-referencing with Databases**: The use of databases like the Human Protein Atlas and CellMarker adds credibility to the annotation, ensuring that the identified markers are consistent with known cell types in breast tissue.<br><br>Weaknesses or areas for improvement:<br>1. **Marker Ranking Consideration**: While the annotation is thorough, it could benefit from a more explicit consideration of the rank or order of markers. The importance of markers appearing earlier in the list could be emphasized more in the analysis.<br>2. **Potential Overlook of Mixed Cell Types**: Although the annotation acknowledges the possibility of basal epithelial and smooth muscle cells, it could further explore the potential for mixed cell types or transitional states, especially in the context of cancer where such phenomena are common.<br><br>Overall, the annotation provides a comprehensive view of the cell types present, with a strong focus on the most probable cell type, myoepithelial cells. There are no obvious misclassifications, and the analysis aligns well with the known biology of breast tissue.<br>
                        </div>
                    </div>
                
        </div>
    </body>
    </html>
    